BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37264704)

  • 1. The clinical impact of the first-trimester nuchal translucency between the 95th-99th percentiles.
    Fantasia I; Catagini S; Zamagni G; Greco P; Bianchini I; Bussolaro S; Quadrifoglio M; Lo Bello L; Monasta L; Ricci G; Faletra F; Feresin A; Stampalija T
    Prenat Diagn; 2023 Jun; 43(7):929-936. PubMed ID: 37264704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array study in fetuses with nuchal translucency above the 95th percentile: a 4-year observational single-centre study.
    Coello-Cahuao E; Sánchez-Durán MÁ; Calero I; Higueras MT; García MA; Rodó C; Maiz N; Plaja Rustein A; Castells-Sarret N; Mediano-Vizuete C; Carreras E
    Arch Gynecol Obstet; 2023 Jan; 307(1):285-292. PubMed ID: 35486155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of prenatal screening with nuchal translucency > 95th centile and below 99th centile: a 4-year observational study with real-world data.
    Zhang B; Zhang LX; Yi J; Wang CH; Zhao Y
    Arch Gynecol Obstet; 2024 Apr; ():. PubMed ID: 38625542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
    Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
    [No Abstract]   [Full Text] [Related]  

  • 5. First-trimester absent nasal bone: is it a predictive factor for pathogenic CNVs in the low-risk population?
    Fantasia I; Stampalija T; Sirchia F; Della Pietà I; Ottaviani Giammarco C; Guidolin F; Quadrifoglio M; Barresi V; Travan L; Faletra F
    Prenat Diagn; 2020 Dec; 40(12):1563-1568. PubMed ID: 32799336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated nuchal translucency, is it time to discuss the cut off?
    Pasquini L; Ponziani I; Spataro E; Masini G; Biancareddu E; Cordisco A; Petraglia F
    Int J Gynaecol Obstet; 2023 Nov; 163(2):540-546. PubMed ID: 37128959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study.
    Hui L; Pynaker C; Bonacquisto L; Lindquist A; Poulton A; Kluckow E; Hutchinson B; Norris F; Pertile MD; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
    Am J Obstet Gynecol; 2021 Nov; 225(5):527.e1-527.e12. PubMed ID: 33957116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal and perinatal outcomes of twin pregnancy discordant for one fetus with nuchal translucency above the 95th percentile.
    Shi X; Liu Q; He W; Liu Y; Rao T; Fang L; Wu J
    J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3152-3157. PubMed ID: 32907415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.
    Su L; Huang H; An G; Cai M; Wu X; Li Y; Xie X; Lin Y; Wang M; Xu L
    Mol Genet Genomic Med; 2019 Aug; 7(8):e811. PubMed ID: 31209990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus.
    Minnella GP; Crupano FM; Syngelaki A; Zidere V; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 May; 55(5):637-644. PubMed ID: 31875326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Birth defects associated with increased nuchal translucency].
    Mendoza-Caamal EC; Grether-González P; Hernández-Gómez M; Guzmán-Huerta M; Aguinaga-Ríos M
    Ginecol Obstet Mex; 2010 Oct; 78(10):533-9. PubMed ID: 21966770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of nuchal translucency thickness at 11 to 14 weeks of gestation in a normal Turkish population.
    Dinç G; Eyüboğlu İ
    Turk J Med Sci; 2021 Feb; 51(1):90-94. PubMed ID: 32777901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
    Baś-Budecka E; Perenc M; Sieroszewski P
    Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased nuchal translucency at 11-13 weeks' gestation and outcome in twin pregnancy.
    Cimpoca B; Syngelaki A; Litwinska E; Muzaferovic A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):318-325. PubMed ID: 31773823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
    Müller MA; Clur SA; Timmerman E; Bilardo CM
    Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?
    Bardi F; Bosschieter P; Verheij J; Go A; Haak M; Bekker M; Sikkel E; Coumans A; Pajkrt E; Bilardo C
    Prenat Diagn; 2020 Jan; 40(2):197-205. PubMed ID: 31697852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and outcome of increased nuchal translucency in usmanu danfodiyo university teaching hospital, Sokoto, Nigeria: A cohort study.
    Sulaiman B; Shehu CE; Panti AA; Saidu SA; Onankpa B; Ekele BA
    Niger J Clin Pract; 2020 Jun; 23(6):864-869. PubMed ID: 32525124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
    Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
    Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of chromosomal microarray in fetuses with increased nuchal translucency.
    Zhao XR; Gao L; Wu Y; Wang YL
    J Matern Fetal Neonatal Med; 2020 May; 33(10):1749-1754. PubMed ID: 30688128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.